Pleiotropic effect of teneligliptin versus glimepiride add-on therapy on hs-CRP and cardiorenal parameters in Indian type 2 diabetes patients: An open-labeled randomized controlled trial
ViewAnalysis of phase 3 study of fixed-dose combination of Dapagliflozin, Glimepiride and Metformin IR in type 2 diabetes mellitus patients aged
ViewAzithromycin to Reduce Mortality — An Adaptive Cluster-Randomized Trial
ViewTeneligliptin as an Adjuvant Therapy in Type 2 Diabetic Management: A Prospective Observational Study
ViewOlmesartan: 360-degree Perspectives Befitting an Angiotensin Receptor Blocker
ViewFenofibrate’s impact on cardiovascular risk in patients with diabetes: a nationwide propensity-score matched cohort study
ViewDapagliflozin and Kidney Outcomes in Hospitalized Patients with COVID-19 Infection- An Analysis of the DARE-19 Randomized Controlled Trial
ViewEffect of a Fixed-dose Combination of Telmisartan/S-amlodipine on Circadian Blood Pressure Compared with Telmisartan Monotherapy: TENUVA-BP study
ViewExpert perspectives on the prescription pattern of levocetirizine+montelukast and fexofenadine+montelukast for the management of allergic rhinitis in the Indian settings
ViewEfficacy of Rosuvastatin in Children with Homozygous Familial Hypercholesterolemia
View